303 related articles for article (PubMed ID: 29229088)
1. Correlation of serum vascular adhesion protein-1 with airflow limitation and quality of life in stable chronic obstructive pulmonary disease.
Amani M; Ghadimi N; Aslani MR; Ghobadi H
Respir Med; 2017 Nov; 132():149-153. PubMed ID: 29229088
[TBL] [Abstract][Full Text] [Related]
2. Correlation of serum fatty acid binding protein-4 and interleukin-6 with airflow limitation and quality of life in stable and acute exacerbation of COPD.
Aslani MR; Ghazaei Z; Ghobadi H
Turk J Med Sci; 2020 Apr; 50(2):337-345. PubMed ID: 31905499
[TBL] [Abstract][Full Text] [Related]
3. Correlations Between Serum Decoy Receptor 3 and Airflow Limitation and Quality of Life in Male Patients with Stable Stage and Acute Exacerbation of COPD.
Ghobadi H; Hosseini N; Aslani MR
Lung; 2020 Jun; 198(3):515-523. PubMed ID: 32211977
[TBL] [Abstract][Full Text] [Related]
4. The Correlation of Serum Brain Natriuretic Peptide and Interleukin-6 with Quality of Life Using the Chronic Obstructive Pulmonary Disease Assessment Test.
Ghobadi H; Aslani MR; Hosseinian A; Farzaneh E
Med Princ Pract; 2017; 26(6):509-515. PubMed ID: 29131048
[TBL] [Abstract][Full Text] [Related]
5. Quality of life in smokers: focus on functional limitations rather than on lung function?
Geijer RM; Sachs AP; Verheij TJ; Kerstjens HA; Kuyvenhoven MM; Hoes AW
Br J Gen Pract; 2007 Jun; 57(539):477-82. PubMed ID: 17550673
[TBL] [Abstract][Full Text] [Related]
6. Features of COPD patients by comparing CAT with mMRC: a retrospective, cross-sectional study.
Huang WC; Wu MF; Chen HC; Hsu JY;
NPJ Prim Care Respir Med; 2015 Nov; 25():15063. PubMed ID: 26538368
[TBL] [Abstract][Full Text] [Related]
7. Discrepancies between modified Medical Research Council dyspnea score and COPD assessment test score in patients with COPD.
Rhee CK; Kim JW; Hwang YI; Lee JH; Jung KS; Lee MG; Yoo KH; Lee SH; Shin KC; Yoon HK
Int J Chron Obstruct Pulmon Dis; 2015; 10():1623-31. PubMed ID: 26316736
[TBL] [Abstract][Full Text] [Related]
8. GOLD Classification of COPD: Discordance in Criteria for Symptoms and Exacerbation Risk Assessment.
Mittal R; Chhabra SK
COPD; 2017 Feb; 14(1):1-6. PubMed ID: 27723367
[TBL] [Abstract][Full Text] [Related]
9. The effect of comorbidities on COPD assessment: a pilot study.
Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
[TBL] [Abstract][Full Text] [Related]
10. The association between objectively measured physical activity and morning symptoms in COPD.
van Buul AR; Kasteleyn MJ; Chavannes NH; Taube C
Int J Chron Obstruct Pulmon Dis; 2017; 12():2831-2840. PubMed ID: 29042764
[TBL] [Abstract][Full Text] [Related]
11. Correlation between serum biomarkers and BODE index in patients with stable COPD.
Liu SF; Chin CH; Wang CC; Lin MC
Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
[TBL] [Abstract][Full Text] [Related]
12. COPD assessment test and severity of airflow limitation in patients with asthma, COPD, and asthma-COPD overlap syndrome.
Kurashima K; Takaku Y; Ohta C; Takayanagi N; Yanagisawa T; Sugita Y
Int J Chron Obstruct Pulmon Dis; 2016; 11():479-87. PubMed ID: 27019598
[TBL] [Abstract][Full Text] [Related]
13. Comparison between COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) dyspnea scores for evaluation of clinical symptoms, comorbidities and medical resources utilization in COPD patients.
Cheng SL; Lin CH; Wang CC; Chan MC; Hsu JY; Hang LW; Perng DW; Yu CJ; Wang HC;
J Formos Med Assoc; 2019 Jan; 118(1 Pt 3):429-435. PubMed ID: 30150099
[TBL] [Abstract][Full Text] [Related]
14. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
[TBL] [Abstract][Full Text] [Related]
15. Differences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analyses.
Kim S; Oh J; Kim YI; Ban HJ; Kwon YS; Oh IJ; Kim KS; Kim YC; Lim SC
BMC Pulm Med; 2013 Jun; 13():35. PubMed ID: 23731868
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of quality of life with the chronic obstructive pulmonary disease assessment test in chronic obstructive pulmonary disease and the effect of dyspnea on disease-specific quality of life in these patients.
Okutan O; Tas D; Demirer E; Kartaloglu Z
Yonsei Med J; 2013 Sep; 54(5):1214-9. PubMed ID: 23918572
[TBL] [Abstract][Full Text] [Related]
17. Factors Associated With Quality of Life in Subjects With Stable COPD.
Ekici A; Bulcun E; Karakoc T; Senturk E; Ekici M
Respir Care; 2015 Nov; 60(11):1585-91. PubMed ID: 26152471
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 and airflow limitation in chemical warfare patients with chronic obstructive pulmonary disease.
Attaran D; Lari SM; Towhidi M; Marallu HG; Ayatollahi H; Khajehdaluee M; Ghanei M; Basiri R
Int J Chron Obstruct Pulmon Dis; 2010 Oct; 5():335-40. PubMed ID: 21037957
[TBL] [Abstract][Full Text] [Related]
19. COPD assessment test score and serum C-reactive protein levels in stable COPD patients.
Kang HK; Kim K; Lee H; Jeong BH; Koh WJ; Park HY
Int J Chron Obstruct Pulmon Dis; 2016; 11():3137-3143. PubMed ID: 27994452
[TBL] [Abstract][Full Text] [Related]
20. Real-life assessment of the multidimensional nature of dyspnoea in COPD outpatients.
Morélot-Panzini C; Gilet H; Aguilaniu B; Devillier P; Didier A; Perez T; Pignier C; Arnould B; Similowski T
Eur Respir J; 2016 Jun; 47(6):1668-79. PubMed ID: 27076585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
